Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, Infusion Systems and Others

Introduction

GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, Infusion Systems and Others” provides key market data on the Japan Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories – Inhalation Systems, Needle Free Injections and Infusion Systems. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Inhalation Systems, Needle Free Injections and Infusion Systems.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. Segments include Dry Powder Inhaler Devices, Metered Dose Inhaler Devices, Infusion Disposable Sets and Others.
- 2009 company shares and distribution shares data for each of the three market categories.
- Global corporate-level profiles of key companies operating within the Japan Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Sepracor Inc., CareFusion Corporation and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Explore investment opportunites in the market.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
GlaxoSmithKline plc
AstraZeneca PLC
Boehringer Ingelheim GmbH
3M Health Care
Novartis AG
Terumo Corporation
Smiths Medical
Baxter International Inc.
JMS CO., LTD.
NIPRO CORPORATION
Daiken Medical Co., Ltd.
TOP Corporation
[Fade out the market survey infos]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What is This Report About? 8
3 Drug Delivery Devices In Japan 9
3.1 Drug Delivery Devices, Market Segmentation 9
3.2 Drug Delivery Devices, Japan, Overall Revenue ($m), 2002-2016 10
3.3 Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2009 12
3.4 Drug Delivery Devices Market, Japan, Category Contribution (%), 2009 13
3.5 Drug Delivery Devices, Japan, Category Volume (Units), 2002-2016 19
3.6 Drug Delivery Devices, Japan, Company Share (2008-2009) 24
4 Infusion Systems In Japan 26
4.1 Infusion Systems, Market Segmentation 26
4.2 Infusion Systems Market, Japan, Revenue Mix ($m), 2009 27
4.3 Infusion Systems Market, Japan, Category Contribution (%), 2009 28
4.4 Infusion Systems Overall Revenue (2002-2016) 29
4.5 Infusion Systems Overall Volume (2002-2016) 33
4.6 Infusion Systems Average Price (2002-2016) 37
4.7 Infusion Systems Distribution Share (2008-2009) 38
4.8 Infusion Systems, Japan, Company Share (2008-2009) 39
5 Inhalation Systems In Japan 41
5.1 Inhalation Systems, Market Segmentation 41
5.2 Inhalation Systems Market, Japan, Revenue Mix ($m), 2009 42
5.3 Inhalation Systems Market, Japan, Category Contribution (%), 2009 43
5.4 Inhalation Systems Overall Revenue (2002-2016) 44
5.5 Inhalation Systems Overall Volume (2002-2016) 48
5.6 Inhalation Systems Average Price (2002-2016) 51
5.7 Inhalation Systems Distribution Share (2008-2009) 52
5.8 Inhalation Systems, Japan, Company Share (2008-2009) 53
6 Needle Free Injections In Japan 55
6.1 Needle Free Injections Overall Revenue (2002-2016) 55
6.2 Needle Free Injections Overall Volume (2002-2016) 58
6.3 Needle Free Injections Average Price (2002-2016) 60
6.4 Needle Free Injections Distribution Share (2008-2009) 61
6.5 Needle Free Injections, Japan, Company Share (2008-2009) 62
7 Overview of Key Companies in Japan Drug Delivery Devices Market 63
7.1 GlaxoSmithKline plc 63
7.1.1 Company Overview 63
7.1.2 Share in the Japan Drug Delivery Devices Market 63
7.2 AstraZeneca PLC 64
7.2.1 Company Overview 64
7.2.2 Share in the Japan Drug Delivery Devices Market 65
7.3 Boehringer Ingelheim GmbH 66
7.3.1 Company Overview 66
7.3.2 Share in the Japan Drug Delivery Devices Market 67
7.4 3M Health Care 68
7.4.1 Company Overview 68
7.4.2 Share in the Japan Drug Delivery Devices Market 68
7.5 Novartis AG 69
7.5.1 Company Overview 69
7.5.2 Share in the Japan Drug Delivery Devices Market 69
7.6 Terumo Corporation 70
7.6.1 Company Overview 70
7.6.2 Share in the Japan Drug Delivery Devices Market 70
7.7 Smiths Medical 71
7.7.1 Company Overview 71
7.8 Baxter International Inc. 71
7.8.1 Company Overview 71
7.9 JMS CO., LTD. 71
7.9.1 Company Overview 71
7.10 NIPRO CORPORATION 72
7.10.1 Company Overview 72
7.11 Daiken Medical Co., Ltd. 72
7.11.1 Company Overview 72
7.12 TOP Corporation 72
7.12.1 Company Overview 72
8 Drug Delivery Devices Market Pipeline Products 73
9 Appendix 79
9.1 Definitions of Markets Covered in the Report 80
9.1.1 Drug Delivery Devices 80
9.2 Research Methodology 82
9.3 Secondary Research 82
9.4 Primary Research 83
9.5 Models 83
9.6 Forecasts 83
9.7 Expert Panels 84
9.8 GlobalData Consulting 84
9.9 Currency Conversion 84
9.10 Contact Us 84
9.11 Disclaimer 85
[Fade out table of contents]

LIST OF TABLES

1.1 List of Tables
Table 1: Drug Delivery Devices, Japan, Overall Revenue ($m), 2002-2016 10
Table 2: Drug Delivery Devices Market, Japan, Category Contribution (%), 2009 13
Table 3: Drug Delivery Devices, Japan Cross-Category Analysis, 2002-2016 14
Table 4: Drug Delivery Devices, Japan, Overall Revenue ($m), Historic, 2002-2009 16
Table 5: Drug Delivery Devices, Japan, Overall Revenue ($m), Forecast, 2009-2016 18
Table 6: Drug Delivery Devices, Japan, Category Volume (Units), 2002-2016 19
Table 7: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2002-2009 21
Table 8: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2009-2016 23
Table 9: Drug Delivery Devices, Japan, Company Share by Revenue ($m), 2008-2009 25
Table 10: Infusion Systems Market, Japan, Category Contribution (%), 2009 28
Table 11: Infusion Systems, Japan, Revenue ($m) by Segment, Historic, 2002-2009 30
Table 12: Infusion Systems Market, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 32
Table 13: Infusion Systems, Japan, Volume (Units) by Segment, Historic, 2002-2009 34
Table 14: Infusion Systems, Japan, Volume (Units) by Segment, Forecast, 2009-2016 36
Table 15: Infusion Systems, Japan, Average Price ($), Historic, 2002-2009 37
Table 16: Infusion Systems, Japan, Average Price ($), Forecast, 2009-2016 37
Table 17: Infusion Systems, Japan, Distribution Share by Revenue ($m), 2008-2009 38
Table 18: Infusion Systems, Japan, Company Share by Revenue ($m), 2008-2009 40
Table 19: Inhalation Systems Market, Japan, Category Contribution (%), 2009 43
Table 20: Inhalation Systems, Japan, Revenue ($m) by Segment, Historic, 2002-2009 45
Table 21: Inhalation Systems, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 47
Table 22: Inhalation Systems, Japan, Volume (Units) by Segment, Historic, 2002-2009 49
Table 23: Inhalation Systems, Japan, Volume (Units) by Segment, Forecast, 2009-2016 50
Table 24: Inhalation Systems, Japan, Average Price ($), Historic, 2002-2009 51
Table 25: Inhalation Systems, Japan, Average Price ($), Forecast, 2009-2016 51
Table 26: Inhalation Systems, Japan, Distribution Share by Revenue ($m), 2008-2009 52
Table 27: Inhalation Systems, Japan, Company Share by Revenue ($m), 2008-2009 54
Table 28: Needle Free Injections, Japan, Revenue ($m), Historic, 2002-2009 55
Table 29: Needle Free Injections, Japan, Revenue ($m), Forecast, 2009-2016 56
Table 30: Needle Free Injections, Japan, Volume (Units), Historic, 2002-2009 58
Table 31: Needle Free Injections, Japan, Volume (Units), Forecast, 2009-2016 59
Table 32: Needle Free Injections, Japan, Average Price ($), Historic, 2002-2009 60
Table 33: Needle Free Injections, Japan, Average Price ($), Forecast, 2009-2016 60
Table 34: Needle Free Injections, Japan, Distribution Share by Revenue ($m), 2008-2009 61
Table 35: Needle Free Injections, Japan, Company Share by Revenue ($m), 2008-2009 62
Table 36: Drug Delivery Devices Market Pipeline Products 73
Table 37: USD to Local Currency, Japan, Average Actual Rate 2002-2009 84
1.2
LIST OF FIGURES

1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 9
Figure 2: Drug Delivery Devices, Japan, Overall Revenue ($m), 2002-2016 10
Figure 3: Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2009 12
Figure 4: Drug Delivery Devices Market, Japan, Category Contribution (%), 2009 13
Figure 5: Drug Delivery Devices Market, Japan, Cross-Category Analysis, 2002-2016 14
Figure 6: Drug Delivery Devices, Japan, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Drug Delivery Devices, Japan, Overall Revenue ($m), Forecast, 2009-2016 17
Figure 8: Drug Delivery Devices, Japan, Category Volume (Units), 2002-2016 19
Figure 9: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2002-2009 20
Figure 10: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2009-2016 22
Figure 11: Drug Delivery Devices, Japan, Company Share (%), 2009 24
Figure 12: Infusion Systems, Market Segmentation 26
Figure 13: Infusion Systems Market, Japan, Revenue Mix ($m), 2009 27
Figure 14: Infusion Systems Market, Japan, Category Contribution (%), 2009 28
Figure 15: Infusion Systems, Japan, Revenue ($m) by Segment, Historic, 2002-2009 29
Figure 16: Infusion Systems, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 31
Figure 17: Infusion Systems, Japan, Volume (Units) by Segment, Historic, 2002-2009 33
Figure 18: Infusion Systems, Japan, Volume (Units) by Segment, Forecast, 2009-2016 35
Figure 19: Infusion Systems, Japan, Company Share (%), 2009 39
Figure 20: Inhalation Systems, Market Segmentation 41
Figure 21: Inhalation Systems Market, Japan, Revenue Mix ($m), 2009 42
Figure 22: Inhalation Systems Market, Japan, Category Contribution (%), 2009 43
Figure 23: Inhalation Systems, Japan, Revenue ($m) by Segment, Historic, 2002-2009 44
Figure 24: Inhalation Systems, Japan, Revenue ($m) by Segment, Forecast, 2009-2016 46
Figure 25: Inhalation Systems, Japan, Volume (Units) by Segment, Historic, 2002-2009 48
Figure 26: Inhalation Systems, Japan, Volume (Units) by Segment, Forecast, 2009-2016 50
Figure 27: Inhalation Systems, Japan, Company Share (%), 2009 53
Figure 28: Needle Free Injections, Japan, Revenue ($m), Historic, 2002-2009 55
Figure 29: Needle Free Injections, Japan, Revenue ($m), Forecast, 2009-2016 56
Figure 30: Needle Free Injections, Japan, Volume (Units), Historic, 2002-2009 58
Figure 31: Needle Free Injections, Japan, Volume (Units), Forecast, 2009-2016 59
Figure 32: GlaxoSmithKline plc, Company Share (%),Japan Drug Delivery Devices Market, 2009 63
Figure 33: AstraZeneca PLC, Company Share (%),Japan Drug Delivery Devices Market, 2009 65
Figure 34: Boehringer Ingelheim GmbH, Company Share (%),Japan Drug Delivery Devices Market, 2009 67
Figure 35: 3M Health Care, Company Share (%),Japan Drug Delivery Devices Market, 2009 68
Figure 36: Novartis AG, Company Share (%),Japan Drug Delivery Devices Market, 2009 69
Figure 37: Terumo Corporation, Company Share (%),Japan Drug Delivery Devices Market, 2009 70
[Fade out list of tables / figures]